Alder Bio stock: buy or sell?

ALDR stock price: $18.88 -0.21% At close on October 21st, 2019

Updated on:
October 21st, 2019


Alder Bio stayed steady an unpleasant -0.21% and closed at $18.88.

Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States, Australia, and Ireland.

Should I buy Alder Bio stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at we prefer those that are simple but successful.

Just 1 of our buy setups matches with Alder Bio stock now:

Buy setupElegible
New all-time highNo
New 52 week highYes
Price crossing up 200d MANo
100d MA crossing up 200d MANo

Is Alder Bio stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. At, we gathered 10 ratings published for ALDR stock in the last 30 days.

Is ALDR a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-17UBS GroupSellNeutral
2019-9-17Credit Suisse Groupn/aNeutral
2019-9-16Needham & Company LLCBuyHold
2019-9-16Morgan StanleyUnderweightEqual Weight
2019-9-16Canaccord GenuityBuyHold
2019-9-16BMO Capital MarketsOutperformMarket Perform
2019-7-10Credit Suisse Groupn/aNeutral
2019-3-14Canaccord GenuityBuyBuy
2019-2-26Cantor Fitzgeraldn/aHold

Alder Bio stock analysis

Daily outlook

Shares of Alder BioPharmaceuticals ended on October at $18.88 and stayed constant an unpleasant -0.21%.

Alder BioPharmaceuticals shares stayed steady -0.21% to $18.88 on October. Since price and SMA200d lines crossed up on September, ALDR climbed $8.82 (87.67%). Since last September when SMA50d and SMA100d crossed up, ALDR price gained $0.07 per share (0.37%).

ALDR stock chart (daily)

Weekly outlook

Alder Bio stayed stable a tight -0.21% this week. By mid September ALDR boosted an exceptional 46.03% in just one week.

Since mid September when ALDR stock price broke up the SMA40w line, it gained $8.82 (87.67%).

ALDR stock chart (weekly)

Alder Bio stock price history

Alder Bio IPO was on May 8th, 2014 at $10.35 per share1. Since then, ALDR stock surged a 82.40%, with a yearly average of 16.50%. If you had invested $1,000 in Alder Bio stock in 2014, it would worth $824.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Alder Bio stock historical price chart

ALDR stock reached 52-week highs on October at $19.12, and all-time highs 2015-07-01 with a price of 54.9.

Alder Bio stock price target is $18.10

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' ALDR stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 5 price forecasts for ALDR stock:
ALDR stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-9-17UBS GroupUpgrades$9.00$19.50116.7%
2019-9-17Credit Suisse GroupReiterates$11.00$19.0072.7%
2019-3-14Canaccord GenuityLowers Target$21.00$20.00-4.8%
2019-2-26Cantor FitzgeraldReiteratesn/a$14.00-
(in average)$14.00$18.1029.0%
Moving in a range from $20.00 and $14.00, the price target for Alder BioPharmaceuticals stock is $18.10. In average, analysts' outlook on ALDR price target is positive, upgrading the forecast by a 29.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

On February, Alder Bio presented its financial report, posting a pretty good growth for the Earnings per Share (EPS) ratio. Analyst expected $-1.01 per share, but Alder Bio posted $-1.19.
ALDR earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2017, Alder BioPharmaceuticals annual sales boosted an astounding 1,332.74% to $1.62 M USD from $0.11 marked in 2016. Likewise, its earnings margin (compared to sales) rocketed to -17,843.05%, that is $-288.88 million.

ALDR annual Sales and Income evolution
2013$19 M-$-20.61 M-109.6%-
2014$55 M190.98%$8.91 M16.3%-143.22%
2016$0.11 M-99.79%$-156.25 M-138277.9%-1,854.09%
2017$1.62 M1,332.74%$-288.88 M-17843.1%84.88%

Quarterly financial results

Reported quarter income marked $-80.09 M with a profit margin of . Profit margin remained constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Alder BioPharmaceuticals sales marked a scary decrease and plummed a -100.00%. Looking back to recent quarterly results, Alder BioPharmaceuticals posted 4 negative quarters in a row.
ALDR quarterly Sales and Income evolution
2017-Q2$0.68 M-$-74.63 M-10926.8%-
2017-Q4$0.94 M37.04%$-54.36 M-5807.4%-27.16%

Alder Bio ownership

When you are planning to buy shares of a stock, it's worth to review its ownership structure.

Alder BioPharmaceuticals shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a of all shares.

For a better context understanding, the following table shows ownership data compared to other related stocks:

Market cap$0.0 M
Total shares0.0 M
Float shares0.0 M
  - Institutional holdings (%)0.0%
  - Insider holdings (%)0.0%
Shares in short selling0.0%

Alder Bio summary

Monday, October 21st, 2019
Day range$18.83 - $19.12
Previous close$18.92
Session gain-0.21%
Average true range$0.09
50d mov avg$14.21
100d mov avg$12.57
200d mov avg$12.67
Daily pattern
Weekly pattern

Alder Bio performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Alder Bio to :
ALDRAlder BioPharmace...81.02%35.24%43.36%

Alder Bio competitors

Unfortunately, we could not find any public company that could be defined as Alder BioPharmaceuticals competitor. This doesn't mean Alder BioPharmaceuticals does not have any competitor in the market, it's just we could not detected it.